Banned drug factories in India exporting to the US

A ProPublica investigation reveals the FDA has allowed substandard drug factories, banned from exporting to the U.S., to continue shipping medications for over a decade, endangering public health.

This investigation exposed that the FDA permitted more than 150 drugs from these unsuitable factories, mostly in India, with serious contamination issues to reach American consumers.

Despite numerous quality complaints and a lack of routine testing, the FDA aimed to avoid drug shortages.

Former FDA officials expressed concerns about potential risks, emphasizing the need for tighter oversight and transparency in the agency's practices.

Patient safety has been compromised as many continue to unknowingly take these risky medications.